Is medical cannabis different from recreational in New York?

New York legalises cannabis through two systems: the Medical Cannabis Program, which began in 2016, and adult-use legalisation under the MRTA, passed in 2021.

• Medical: patients need a licensed health care provider to certify eligibility based on a qualifying condition, must register with the state, and buy from designated medical dispensaries.
• Adult-use: adults 21 and older may possess, purchase, and use cannabis from licensed adult-use dispensaries, with possession and cultivation limits set by the MRTA.
• Medical products focus on therapeutic formulations and tailored CBD/THC ratios; adult-use products are generally geared toward psychoactive effect.
• Medical patients receive enhanced protections for patient rights and privacy; adult-use consumers receive the standard protections available to adults.

Qualifying conditions accepted for medical certification include:

• Cancer
• HIV/AIDS
• Parkinson's disease
• Multiple sclerosis
• Epilepsy
• Chronic pain
• Post-traumatic stress disorder (PTSD)
• Substance use disorder

After certification, patients register with the New York State medical cannabis program. Only registered patients may purchase from approved medical dispensaries, and there is no minimum age for medical use once certified. Recreational cannabis is limited to adults 21 and older, with no certification or qualifying condition required.

Minors can access medical cannabis under supervised provisions:

• Certification must come from a licensed health care provider experienced in treating minors.
• A parent or legal guardian must serve as the designated caregiver.
• The caregiver purchases, possesses, and administers the products.

• Certified patients may possess a 60-day supply of their certified medicine or the standard recreational limits — whichever is greater.
• Adults 21 and older may carry up to three ounces of cannabis flower outside the home and store up to five pounds inside the home.
• Medical patients aged 18 or older may cultivate up to six plants at home for personal use.
• Recreational users must be at least 21 to grow, with the same six-plant household allowance.

Medical cannabis is subject to stricter testing than adult-use product, including screening for pesticides, heavy metals, mould, and residual solvents, plus verification of cannabinoid potency.

• Laboratory analysis conducted by state-certified third-party labs.
• Detailed reporting of cannabinoid profiles and terpene content.
• Batch-by-batch testing to maintain purity and potency standards.

Medical formulations are designed around therapeutic goals:

• Higher CBD-to-THC ratios for inflammation, anxiety, or seizures without strong psychoactive effect.
• Balanced or moderate THC for pain relief while limiting intoxication.
• Formulations emphasising non-intoxicating cannabinoids and terpenes.

Recreational products generally prioritise higher THC concentration, potency, and flavour variety rather than precise therapeutic profiles.

• Employment: employers cannot discriminate against a certified patient solely for their status as a medical cannabis user, subject to exceptions for safety-sensitive positions regulated by federal law.
• Housing: landlords may not deny residency or evict tenants purely for lawful medical cannabis use.
• Privacy: patient certification and treatment information is protected, limiting disclosure without consent.
• Caregivers: patients may designate a registered caregiver to purchase, transport, and administer cannabis on their behalf.

Medical cannabis is taxed at a reduced rate, typically the state’s standard sales tax without the additional excise taxes applied to adult-use product. Recreational cannabis carries a state excise tax based on THC content or product category plus local sales taxes, which adds a substantial markup at retail.

• Certified patients often pay less per gram or dose because dispensaries pass on the lower tax burden.
• Recreational consumers bear higher costs reflecting the extra layers of taxation.
• Cannabis is not covered by insurance, so lower retail prices are what reduce patient out-of-pocket costs.

Medical dispensaries are built around therapeutic support:

• Pharmacist consultations covering cannabinoid profiles, drug interactions, and dosing.
• Personalised care plans developed from medical history, symptoms, and treatment goals.
• Product selection with specific CBD-to-THC ratios and delivery methods for particular conditions.
• Enhanced privacy protections for sensitive health discussions.

Recreational dispensaries focus on adult-use retail:

• Wide product variety aimed at general consumer preference, emphasising potency and choice.
• Staff provide product information on effects and consumption methods rather than health consultations.
• A streamlined purchasing process with no certification or care plan required.

You can look up licensed retailers in New York in the dispensary directory.

Some states with reciprocity agreements recognise a New York patient’s certified status, allowing possession and use there without re-certifying locally. Reciprocity applies only to medical patients; adult-use legalisation is state-specific, so recreational cannabis purchased in New York cannot legally be transported or used in another state. Requirements vary widely, so verify each destination state’s policy before travelling.